What 6 Analyst Ratings Have To Say About Taysha Gene Therapies
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Taysha Gene Therapies (NASDAQ:TSHA) in the last quarter, with 5 bullish and 1 somewhat bullish ratings. The average price target has increased by 70.75% from the previous average of $4.00 to $6.83, implying an upside from the current price of $2.13.
August 15, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bullish analyst ratings and an increased price target suggest a potential upside for Taysha Gene Therapies.
The bullish ratings from analysts indicate a positive outlook for Taysha Gene Therapies. The significant increase in the average price target also suggests that analysts believe the stock has potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100